Improving Cancer On-treatment Symptom Management

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study ID
NCT04589247
Status
Completed

Conditions

  • Cancer
  • Gastrointestinal Cancer
  • Lung Cancer
  • Thoracic Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

Patient-reported outcome measures (PROMs) is an umbrella term that refers to any report on a health status measure that is reported directly by the patient, without the influence of clinicians or anyone else. PROMs have been shown to more closely reflect a patient's daily health status when compared to physician-reported measures. However, research is needed to evaluate if patient symptom reporting during definitive-intent radiotherapy allows earlier and improved detection of treatment toxicity. The IMPROVE pilot study will describe the proportion of patients with cancer with changes in physician-perception of treatment-related toxicity that result from routine physician review of PROMs reported during definitive radiotherapy.

Key Dates

Start date
Nov 16, 2020
Status verified
Sep 2025
Primary completion
Jul 23, 2023
Completion
Jun 30, 2025

Study Design

Enrollment
104 participants (actual)

Arms

  • Arm: Patients with cancer treated with definitive-intent radiotherapy
    Histologically confirmed loco-regional to advanced primary cancer, including but not limited to lung cancer, esophageal, or gastro-intestinal cancers at risk of developing radiotherapy-related toxicity.

Primary Outcome Measure

Participants With Change in Their Physician-assessed Burden Score [ Time Frame: Up to 2 months ]

Locations (4)

FacilityCityStateZIP
Bayview Medical CenterBaltimoreMaryland21227
Johns Hopkins Sidney Kimmel Comprehensive Cancer CenterBaltimoreMaryland21231
Khinh VoongBaltimoreMaryland21230
Suburban HospitalBethesdaMaryland20814

Find similar trials in Baltimore, MD

By condition

Related Studies